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Abstract
Background: In the United States, preterm birth (PTB) before 37 weeks gestational age occurs at an unacceptably
high rate, and large racial disparities persist. To date, medical and public health interventions have achieved limited
success in reducing rates of PTB. Innovative changes in healthcare delivery are needed to improve pregnancy
outcomes. One such model is CenteringPregnancy group prenatal care (GPNC), in which individual physical
assessments are combined with facilitated group education and social support. Most existing studies in the
literature on GPNC are observational. Although the results are promising, they are not powered to detect
differences in PTB, do not address the racial disparity in PTB, and do not include measures of hypothesized
mediators that are theoretically based and validated. The aims of this randomized controlled trial (RCT) are to
compare birth outcomes as well as maternal behavioral and psychosocial outcomes by race among pregnant
women who participate in GPNC to their counterparts in individual prenatal care (IPNC) and to investigate whether
improving women’s behavioral and psychosocial outcomes will explain the potential benefits of GPNC on birth
outcomes and racial disparities.
Methods/design: This is a single site RCT study at Greenville Health System in South Carolina. Women are eligible
if they are between 14–45 years old and enter prenatal care before 20 6/7 weeks of gestational age. Eligible,
consenting women will be randomized 1:1 into GPNC group or IPNC group, stratified by race. Women allocated to
GPNC will attend 2-h group prenatal care sessions according to the standard curriculum provided by the Centering
Healthcare Institute, with other women due to deliver in the same month. Women allocated to IPNC will attend
standard, traditional individual prenatal care according to standard clinical guidelines. Patients in both groups will
be followed up until 12 weeks postpartum.
Discussion: Findings from this project will provide rigorous scientific evidence on the role of GPNC in reducing the
rate of PTB, and specifically in reducing racial disparities in PTB. Establishing the improved effect of GPNC on
pregnancy and birth outcomes can change the way healthcare is delivered, particularly with populations with
higher rates of PTB.
Trial registration: NCT02640638 Date Registered: 12/20/2015.
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Background
Preterm Birth
It is well known that preterm birth (PTB) occurs at
unacceptably high rates within the United States (U.S.),
where 9.6% of babies were born preterm at less than
37 weeks gestational age in 2015 [1]. Large racial dispar-
ities persist, particularly between White and Black
women; the latter had a 13.4% preterm birth rate in
2015 [1]. PTB is the leading cause of newborn death and
disability. Moreover, the racial disparities in the newborn
period have the potential to contribute to disparities in
chronic disease, academic achievement and economic
opportunity across the lifespan [2–4]. To date, medical
and public health interventions have achieved limited
success in improving rates of PTB. The causes of poor
birth outcomes and health disparities are complex, involv-
ing biological, behavioral, psychosocial, socio-demographic,
environmental, and medical factors [2]. Interventions that
do not address these factors in a comprehensive way will
have limited success.
Prenatal care has been the foremost strategy to im-
prove pregnancy and birth outcomes in the U.S. Increas-
ing access to individual prenatal care (IPNC) in the last
twenty years has marginally improved rates of PTB, but
has not made any headway in reducing racial disparities
in birth outcomes [5–7]. Most IPNC appointments are
short (10–15 min) and focus more on triaging medical
risks, with limited time for psychosocial interventions or
health promotion [8, 9]. Women are often referred to
childbirth education or ancillary services to address
these needs [10]. Deviation from recommended prenatal
care content is associated with PTB and low birth weight
(LBW), indicating the importance of prenatal care
models that are structured to provide comprehensive
content [11]. In addition, psychosocial factors during
pregnancy (e.g. stress, anxiety, depression, and coping
responses) are gaining increased attention as critical
contributing factors to poor birth outcomes; however,
the current IPNC model does not adequately consider
these factors [12]. Innovative models in prenatal care
that can address not only physical risk assessment,
but also women’s psychosocial wellbeing are therefore
highly desired.
CenteringPregnancy group prenatal care model
The CenteringPregnancy group prenatal care (GPNC)
model is distinctly different from the traditional practice
of IPNC, requiring a paradigm shift in health care deliv-
ery for obstetric healthcare providers and fundamental
changes to the patient-provider interaction. In this
model, developed and trademarked by the Centering
Healthcare Institute (CHI) (Boston, MA), groups of 8–
12 women who are all due to deliver in the same month
receive their medical care in a series of ten two-hour
group sessions which take place through the second and
third trimesters [13, 14]. The group sessions begin with
patients measuring their own weight and blood pressure,
followed by an individual physical assessment from a
credentialed health care provider (either a physician or a
nurse practitioner/midwife). Once these assessments are
complete, the group meets together for structured
discussion and activities that follow the curriculum de-
veloped by the CHI. Group sessions also include time
for socialization, which encourages group members to
develop relationships with one another. Group session
topics are organized by relevancy to gestational age
(Table 1). The model allows the provider to adapt the
content according to the needs and priorities of the
participants, with deviations from the curriculum noted
to be addressed at a later session. Women are en-
couraged to bring a support person (e.g., boyfriend,
husband, friend, family member) for group sessions.
CHI has established a site training and annual certifi-
cation process to assure consistency and quality in
implementation for obstetric practices offering GPNC
[15]. This model has been implemented in several
hundred practices in the U.S. [15].
There is promising evidence from both obstervational
studies and radomized controlled trials (RCT) that sug-
gests participation in GPNC is associated with reduc-
tions in preterm birth and low birth weight [16–19].
These findings have not been consistently reported in
other studies [20–22]. The existing literature is limited
by the small size of the previously randomized trials, as
well as selection bias of the observational studies.
Within this context, there is evidence that GPNC may
result in reducing the racial disparity in preterm birth
for Black women [16, 17]. Racial disparities in health
have roots in inequalities in the provision of healthcare
at the system level, the provider level, and the patient
level. GPNC is designed to begin to address the racial
disparities in all three levels. First, GPNC includes more
patient-provider interaction time, with an average cumu-
lative patient-provider interaction time of about 20 h
throughout the pregnancy in GPNC, compared to 2 h
for IPNC. More patient-provider interaction is believed
to help develop the patients’ trust in their provider.
Second, GPNC may reduce racial disparities in health-
care arising from unintentional prejudice and discrimin-
ation from healthcare providers, by allowing providers
to develop a more robust understanding of patients’
family structures, social networks, employment or
school, and physical home environment. Lastly, at the
patient level GPNC is designed to promote goal setting
and self-care of patients, empowering women to be-
come more engaged in their health care and managers
of their health by taking the responsibility for some of
their health care.
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Current research gaps
Although this GPNC model has been successfully imple-
mented in several hundred practices in the U.S., there
are several significant gaps in the current literature.
Existing studies are primarily observational studies that
vary widely in quality, many of which are limited by self-
selection bias and potential confounding [16, 18, 23, 24].
At the time we developed this proposal, only three RCTs
had been published, but with mixed results. A secondary
analysis of a study that was designed to examine GPNC’s
impact on HIV risk behaviors and sexually transmitted
infection demonstrated a 33% reduction in the odds of
PTB in the GPNC group as compared with the control
group [17]. The women in this study were younger than
25 years of age. A small trial in military settings did not
find any significant difference in PTB or other birth out-
comes [25]. The third trial in Iran also did not find any
significant difference in PTB or LBW [26]. None of these
studies were adequately powered to determine differ-
ences in rates of PTB, or the racial disparities in PTB in
medically low risk women across all reproductive ages.
The mechanism by which GPNC may improve birth
outcomes is unknown, but existing research suggests
that GPNC contributes to positive psychosocial and/or
behavioral changes in women [24]. Participation in
GPNC has been associated with higher rates of adequate
prenatal care, breastfeeding initiation, less excessive ges-
tational weight gain, greater likelihood of using vitamin
supplements during pregnancy, improved food security,
and more knowledge for prenatal care and more pre-
pared for labor and delivery [17, 19, 23, 25, 27–34].
Qualitative research indicates women generally find
GPNC to be a positive experience, meeting many of
their preferences for care [17, 19, 35–38]. Although
these results are promising, no studies have evaluated
whether improving these psychosocial and/or behavioral
factors will explain the potential benefits of GPNC on
racial disparities in birth outcomes.
The current study addresses the most significant gaps
in the current GPNC literature: the lack of a rigorously
designed clinical trial to assess the impact for GPNC on
PTB and the racial disparity in preterm birth. This study
will also measure GPNC’s effects on patient activation,
engagement, stress, and health behaviors as they relate
to birth outcomes and answer whether improving these
maternal psychosocial and behavioral factors will explain
the potential benefits of GPNC on birth outcomes or on
racial disparities.
Preliminary research
In 2012, we published a retrospective study of 316
women who participated in GPNC compared with 3,767
women in IPNC [16]. The adjusted odds ratio for PTB
for women in GPNC care was 0.53 (95% CI: 0.34, 0.81)
as compared to women in the IPNC. The racial disparity
in PTB between Black women and White women was
also diminished for women in GPNC: the Black-White
difference of PTB was 1.0% in the GPNC and 2.4% in
the IPNC group. In 2012–2013, we conducted a mixed
methods prospective cohort study comparing the effect-
iveness of GPNC to IPNC on women’s psychosocial
health [24, 33]. We recruited 248 women, retaining 89%
of participants through pregnancy and 84% into the
postpartum period. Women completed surveys at two
points during pregnancy and once in the post-partum
period. Among women with inadequate initial social
support, GPNC participants scored 3.16 points lower
(P = 0.03) on a scale of prenatal distress in late preg-
nancy. Among women with high initial prenatal distress,
GPNC participants scored 7.96 points higher (P = 0.008)
on a measurement of planning and preparation coping in
late pregnancy [24].
Preliminary data from our retrospective and prospect-
ive studies demonstrate the potential for GPNC not only
to reduce PTB, but also to reduce racial disparities in
PTB. Our preliminary data also indicates that GPNC
improves women’s psychosocial outcomes as well, par-
ticularly for those reporting high levels of stress in
early pregnancy. By using a RCT design, this pro-
posed study will reduce the possibility of selection
Table 1 CenteringPregnancy group prenatal care (GPNC) curriculum outline
1 12–16 weeks Prenatal testing, nutrition, healthy lifestyle choices Exercise
2 16–20 weeks Body changes in pregnancy, common discomforts, oral health
3 20–24 weeks Relaxation and stress reduction, breastfeeding Gestational diabetes
4 24–28 weeks Family relationships, violence and abuse, family planning, preterm labor Breastfeeding
5 26–30 weeks Labor, birth facility Stress management/relaxation
6 28–32 weeks The birth experience
7 30–34 weeks Newborn care
8 32–36 weeks Pregnancy to parenting transition, postpartum emotions, kick counts Nutrition
9 34–38 weeks Newborn safety, putting it all together Preterm labor
10 36–40 weeks Newborn care, growth and development, home and family changes
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bias and influences from potential confounding, and
have adequate power to conclusively assess the effi-
cacy of GPNC compared with IPNC on rates of PTB
and racial disparities in birth and other outcomes
among White and Black women.
Specific aims and hypotheses
The proposed study will employ a RCT design ad-
equately powered to detect difference in PTB by inter-
vention and race. The study will be conducted in a
large prenatal care provider in South Carolina (SC),
with historically high PTB rates of 16.4%. The pro-
posed study builds on an established research program
focused on assessing the impact of GPNC vs. IPNC on
birth outcomes and will investigate the following
Specific Aims:
Specific Aim 1
To compare the rate of PTB prior to 37 weeks gesta-
tional age and other selected birth outcomes and preg-
nancy complications (e.g. birth weight, caesarean section
rate) among women who participate in CenteringPreg-
nancy GPNC to their counterparts in IPNC.
Study hypothesis 1
Women who participate in GPNC will have a lower rate
of PTB and other improved birth outcomes as compared
to their counterparts in IPNC.
Specific Aim 2
To compare the risk difference of PTB and other
selected birth outcomes of Black women vs. White
women in GPNC to the risk differences of Black women
vs. White women in IPNC.
Study hypothesis 2
The risk difference of PTB and other selected birth
outcomes between Black and White women in the
GPNC group is smaller than that in the IPNC group.
Specific Aim 3
To compare whether women in the GPNC have im-
proved maternal psychosocial (i.e. activation, enga-
gement, stress) and behavioral (i.e. smoking, healthy
eating, health practices) outcomes as compared to their
counterparts in IPNC and to explore whether improving
certain maternal psychosocial and behavioral outcomes
will explain the potential benefits of GPNC on racial
disparities in birth outcomes.
Methods/design
Ethical approval
The study protocol (GHS Pro00043994) was approved
by Institutional Review Board (IRB) of the Greenville
Health System and Clemson University in June 2015. All
the study participants will sign written consenting form
before they are enrolled in the study.
Study design and setting
This proposed study will employ an un-blinded RCT
design to assess the efficacy of GPNC compared with
IPNC on rates of PTB and racial disparities in birth
outcomes among White and Black women. Eligible
women will be recruited at the time of entry to pre-
natal care, and will be followed through delivery and
for 12 weeks postpartum. All research activities will
be conducted at the Greenville Health System (GHS)
Obstetrics (OB) Center and ultrasound unit, located
in Greenville, SC. Greenville is part of a metropolitan
area with a population of approximately 640,000
people, and is approximately 80% urban and 20%
rural [39, 40]. The practice has been serving women
in the area for more than 40 years, with an annual
delivery volume of approximately 2,750 women. The
GHS OB Center first began offering GPNC in 2008,
and has maintained annual site approval from the
CHI since that time. To date, 3,633 patients have
attended Centering groups at this practice.
Patient population
The target population consists of medically low-risk
pregnant women of different races/ethnicities. In our
retrospective cohort study published in 2012, our study
population in the comparison group included 45.8%
non-Hispanic White, 25.5% non-Hispanic Black, 22.2%
Hispanic and 6.5% “Other” race/ethnicity [21]. We ex-
pect that our current study population will be similar.
To be eligible for this study, women will 1) be between
14–45 years of age, and 2) enter prenatal care before
their 20th week of gestation. Study exclusion criteria
include 1) medical complications of pregnancy which
would preclude prenatal care provision by nurse pra-
ctitioners or participation in group care (e.g. pre-
gestational diabetes, severe chronic hypertension, active
pulmonary tuberculosis, massive morbid obesity or
severe psychiatric illness), 2) multiple gestation, 3) le-
thal fetal anomalies, and 4) low literacy. The exclusion
criteria were set to limit the study participants as low-
risk patients, which is consistent with both the GPNC
model design and the scope of medical practice of
nurse practitioners/nurse midwives who provide GPNC.
Women who have participated in this study in a previous
pregnancy will also be excluded, in order to maintain in-
dependence. Based on our preliminary data, application of
these criteria will result in an estimated exclusion of 10%
of women for late entry to care and 8% for pre-existing
medical complications. The exclusion criteria will be ap-
plied to all women before randomization. We will track
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demographic characteristics and reasons for exclusion for
women who are ineligible for the study as well as for those
who are eligible but decline participation.
Participant recruitment and screening
We propose to recruit and follow 3,160 (N = 1,580 in
each group) pregnant women (see section for sample
size calculations). Approximately 250 women begin
prenatal care at the GHS OB Center each month, and
75% of them will be eligible for the proposed study
(180 eligible women per month). The provider will
screen all new patients presenting to the practice for
prenatal care (at the first prenatal visit) for eligibility
and to introduce the study to eligible women. Given
our previous recruitment rate of 50%, we estimate
that the targeted study sample size will be achieved
in 3 years. At the time of the nurse education visit at
the GHS OB Center, all patients will be screened for
study eligibility based on review of medical records
and a series of screening questions answered by the
GHS intake nurses. The final eligibility screening will
take place after the patient is scheduled with a healthcare
provider. This may be the same day, or may be a separate
day from the nurse education visit. Once the history and
physical exam has been completed, the research nurses
will approach eligible patients for study enrollment.
Patients will be taken to a quiet space to have the
study explained. The enrollment process involves a
face-to-face interview with one of the study team for
verification of study eligibility and counseling regard-
ing study procedures, potential benefits and risks,
prior to obtaining written consent. Recruitment began
in July 2016 and will be monitored monthly. Figure 1
describes the flow of participants through the study
recruitment and data collection.
Randomization and masking
Randomization
Women who are eligible for the study will be offered
participation. Women who are interested in participa-
tion will have the opportunity to ask questions, confirm
interest, provide consent, undergo group assignment, as
well as complete the baseline data collection (Survey 1).
Women who agree to participate will be randomized
1:1 to IPNC or GPNC based on computer-generated
group assignment. These assignments will be stratified
by race and ethnicity (Black, White, Hispanic, Mixed,
and Other).
Fig. 1 Flow chart of patient recruitment and follow up
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Masking
Due to the nature of the intervention, it is not possible
to blind the group assignment to the participants and
providers, but we will mask the providers to the study
data. In addition, we will mask the data analysts regard-
ing the group assignment to reduce bias.
Interventions
GPNC (intervention) group
Women will be grouped with other women who are all
due to deliver in the same month, and will receive their
routine prenatal care together during ten 2-h group ses-
sions meeting CHI’s established standards for Centering-
Pregnancy. Women will receive a patient notebook for
their health information, educational materials, and
activities to promote goal setting and self-care. During
the first 30 min of each group session, women will
measure and record their own weight and blood pres-
sure, and then a credentialed healthcare provider (nurse
practitioner, nurse midwife, or physician) will conduct a
brief physical assessment in a semi-private area of the
group space. Following the individual health assess-
ments, the healthcare provider and a co-facilitator will
lead the group discussion for the remaining 60–90 min
of each session. Topics discussed throughout sessions
include pregnancy and nutrition, childbirth preparation,
exercise, stress management, relationships, and parent-
ing (see Table 1). Women randomized to GPNC will
have access to additional IPNC visits (outside of the ten
scheduled group sessions) as needed to address compli-
cations that may arise between group sessions. The
GPNC curriculum is designed to be culturally appropri-
ate and the study site will deliver the intervention in
both English and Spanish.
IPNC (control) group
Women will receive standard, traditional individual
prenatal care in accordance with the schedule of visits
recommended by the American College of Obstetricians
and Gynecologists [41]. Women will attend monthly
visits for the first 28 weeks of pregnancy, every two to
three weeks until 36 weeks gestational age, then weekly
until delivery. Visits will include ongoing physical assess-
ment as well as patient education on common complica-
tions of pregnancy, childbirth preparation, breastfeeding,
and other relevant topics as needed. Women random-
ized to IPNC will not attend GPNC sessions.
Both groups
Women will receive routine medical screenings as well
as specialized tests, interventions, and referrals depend-
ing on risk factors and the course of pregnancy [41].
Women with a history of previous preterm birth who
qualify for progesterone treatment will receive it [42].
Compliance, cross-over, and follow-up
Aspects of prenatal care provision and participation will
be assessed through medical record review and patient
surveys, to measure compliance of both groups, includ-
ing detailed data for each participant’s use of prenatal
care services.
Women who have a miscarriage or leave the practice
and deliver their baby at a different hospital system will
be treated as lost to follow-up in the final analysis. How-
ever, we will make every effort to obtain data for women
who deliver at other facilities by requesting medical
records when we know the location of delivery, and by
obtaining their birth outcomes data through the vital
statistics database with the SC Department of Health
and Environmental Control.
No matter the directions and the reasons of cross-
over and regardless of the number of missed prenatal
care visits, participants will be kept in their original as-
signments, as the primary analysis follows the intent-
to-treatment approach. We will also do a secondary
analysis measuring outcomes “as treated,” using pa-
tients who attend at least five visits of their assigned
model of care.
Retention plan
Retention of the research participants will be one of
the most important tasks of this study. Retention be-
gins at the time of recruitment, when our research
team establishes a positive rapport with the research
subjects. This includes providing information in a
friendly manner, being responsive to their concerns,
providing women with enough detail to understand
the requirements of participation and stressing the
importance of the potential research findings. Special
efforts that will be taken to minimize the loss to
follow-up include: 1) provide reminder text messages
(will be made 3 days before each study visit), 2) limit
participant burden by having recruitment and survey
activities conducted when women are already at the
OB Center, 3) provide child care for women attending
the longer group care sessions, and 4) provide incen-
tives/compensations. In our previous prospective stud-
ies, we have achieved an excellent retention rate: 92%
at delivery and 80% at postpartum visits. We were
able to accomplish this through extensive follow-up
with patients via phone calls and text messages,
friendly research staff, and incentives that increased
in value as they went through the study. For this
study, we are budgeting $75 per patient (in both
groups) for incentives. We will offer gift cards at:
completion of randomization and the Survey 1 ($25),
attending 5 visits in the assigned group treatment and
completion of the Survey 2 after 30 weeks gestational
age ($50).
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Data collection
For this study, data will be collected at the following 3
time points: 1) At the time of Baseline Visit (8–23 weeks
of gestational age), women will undergo group assign-
ment and complete the baseline data collection (Survey
1); 2) After 30 weeks gestational age, research nurses will
meet participants prior to or after their prenatal care
appointment to administer the second survey (Survey 2);
and 3) Postpartum data collection will be conducted
after women attend their postpartum visit and consist of
medical chart abstraction, and will not require patient
contact. The study surveys will be administered elec-
tronically. Patients’ medical information will be collected
from the electronic medical record (EMR). Regular data
review/reports will be generated through the EMR to
monitor enrollment, group balance, and the timing of
the reminder calls & patient incentives. The overall
timeline for study visits and data collection is summa-
rized in Table 2.
Study outcomes
The primary study outcome is PTB (defined as birth at
less than 37 weeks gestation).
The other study variables are
1) Birth outcomes and pregnancy complications: For
example, birth weight; APGAR score; admission to
neonatal intensive care unit; intrauterine fetal
demise; neonatal death; maternal anthropometric
measures; gestational weight gain; pre-eclampsia;
gestational hypertension; gestational diabetes;
intrauterine growth restriction; macrosomia
(birth weight > 4000 g); hospital admission during
pregnancy and the reason; mode of delivery;
induction and reason.
2) Maternal psychosocial measures: For example, a)
Patient Activation Measure (13 items assessing
confidence, knowledge, and skills in managing health
and healthcare); b) Coping Inventory (15 items
reflecting a range of coping strategies to manage
preparing for a baby, adapted from established
coping scales with additional items developed
through focus groups and pilot testing with
pregnant women) [43]; c) Prenatal Distress
Questionnaire (a17-item scale assesses common
worries and stressors during pregnancy, including
concerns about labor and delivery, paying for the
baby’s expenses, and managing work, relationships,
and childcare) [44]; d) Perceived Stress Scale (a
generalized measure assessing how overwhelmed
people feel about their life circumstances [45, 46]; e)
Stress Management Practices subscale of the Health
Promoting Lifestyle Profile II [47, 48]; f ) Prenatal
Anxiety (13 items measures the emotional state of
anxiety arising from women’s concerns about their
pregnancy) [49]; g) Depression (The Center for
Epidemiological Studies Depression Scale) [50]; h)
Shift and Persist (14 item scale measures resilience)
[51]; i) Everyday Discrimination Scale [52]; j)
Discrimination in Prenatal Care (derived from
PRAMS, Centers for Disease Control and
Prevention, 2014]; k) Adverse Childhood Experience
Study questions (adapted from the Behavioral Risk
Factor Surveillance System questionnaire 2014
version) [53]; l) Support from Baby’s Father [54]; m)
Perceived Family Support [55]; n) Role of religiosity
in dealing with stress, and o) Perceived
Neighborhood Safety.
3) Maternal behavioral and other measures: for
example, maternal smoking, alcohol and marijuana
use; pregnancy intention; physical activity, dietary
intake and multivitamin use; housing instability,
access to healthcare, food insecurity, income,
breastfeeding at hospital discharge and
postpartum visit.
4) Race/Ethnicity: Identifying the race of participants
will be our most important quantitative measure.
Indeed, the epidemiologic literature suggests that the
categories of race and ethnicity reflect distinct social
and environmental influences rather than actual
genetic variations between populations [56–59]. We
appreciate that race is more of a social than biologic
construct and differences in health outcomes are
likely due to the broader social and environmental
differences observed between racial groups.
Therefore, we will plan on using patient self-report
of race and ethnicity, based on the 2020 U.S. Census
categories. These categories will be used as our
primary definition in the main analyses. Additionally,
we will provide a narrative space for women to
self-identify racial categories which do not fit neatly
into the options provided, as well as questions about
cultural heritage and country of origin. Finally, we
will ask women about their socially assigned race
and ethnicity (how an individual’s race/ethnicity is
classified by others), since this has also been
associated with differences in health outcomes
[56, 60]. Such additional information will be used in
exploratory and sensitivity analyses.
5) Other demographic information: For example,
education, employment, marital status, income,
and insurance.
6) Reproductive history: For example, pre-pregnancy
weight, previous history of preterm birth, and
numbers of live birth and prior pregnancies.
7) Interconception care: For example, attendance at
postpartum visit, and postpartum contraception use.
Chen et al. BMC Pregnancy and Childbirth  (2017) 17:118 Page 7 of 13
Table 2 Data collection and outcome measurement
Gestational age
<23 week (Survey 1)
Gestational age
30+ week (Survey 2)
12-week Postpartum
medical chart review
Birth outcomes and pregnancy complications
Gestational age at delivery X
Birth weight X
APGAR scores X
Admission to neonatal intensive care unit (NICU) X
Intrauterine fetal demise X
Neonatal death X
Pre-eclampsia X
Gestational hypertension X
Gestational diabetes X
Intrauterine growth restriction X
Macrosomia (weight >4000 g.) X
Hospital admission during pregnancy, reason X
Induction and reason X
Maternal behavioral and other measures
Maternal smoking, alcohol and marijuana use X X X
Physical activity, dietary intake, and multivitamin use X
Maternal psychosocial measures
Patient activation measure (PAM) X X
Prenatal planning and preparation coping X
Prenatal anxiety, and depressive symptoms X X
Shift and Persist X
Discrimination in prenatal care X
Stress management X
Perceived family support X
Support from baby’s father & relationship with baby’s father X
Life stressor, financial stressor and housing instability in pregnancy X
Perceived stress and neighborhood safety X
Everyday discrimination scale X
Role of religious on dealing with stress X
Adverse childhood experience X
Interconception care
Attendance at postpartum visit X
Postpartum contraception use X
Demographics
Race and ethnicity X
Age, income, education, marital status, insurance, employment, household
characteristics
X
Reproductive history
Pre-pregnancy weight X
Previous preterm birth X
Number of prior pregnancies, live births, and complications X
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Prenatal care process evaluation
Aspects of prenatal care provision and participation will
be assessed through patient survey 2, medical record
review, and existing management information systems to
measure fidelity of both models and women’s experi-
ences with care. Detailed data for each participant’s use
of prenatal care services, including timing of prenatal
care entry, number of visits, GPNC or IPNC visit type,
provider identifier, and continuity of provider, will be
collected from medical charts and will be used to
describe prenatal care use.
In survey 2, all patients will complete
1) A subset of questions from the Pregnancy
Empowerment Scale: to assess women’s engagement
in their health care and in making their pregnancy
healthy [61];
2) Attendance of support people: Women will report
who attended prenatal care with them in a
supportive role and how often.
GPNC provision will be monitored additionally through
1) Perceived Cohesion Scale: This brief, four-question
scale measures patients’ sense of belonging and
satisfaction with their group;
2) Adherence to GPNC educational curriculum, group
size, and continuity: GPNC facilitators and the
Project Coordinator currently track curriculum
topics covered across sessions, group composition,
and measures of GPNC fidelity for at least one
session per group. These will be copied as part of
data collection for this study;
3) Annual fidelity review results: The OB Center
participates in annual fidelity reviews with the
Centering Healthcare Institute and has maintained
high fidelity to the GPNC model since its first
assessment in 2010. Fidelity reviews include a site
visit by Centering Healthcare Institute faculty,
record reviews, interviews, and observation. The
OB Center’s fidelity results will be monitored
through the study to assure key elements of the
model are in place.
IPNC provision will be monitored additionally through
medical charts review: IPNC’s educational and coun-
seling topics will be assessed by reviewing medical charts
of a randomly selected sample after women have
delivered, stratified by provider.
Mechanism for reporting adverse event
Minimal risk to the patient is associated with this study,
since patients in both arms will receive prenatal care
which meets or exceeds the standards set by the American
College of Obstetricians and Gynecologists. We plan to
report any adverse event to the IRB and the NIH as appro-
priate. An adverse event report form will be generated and
used for collecting adverse events during the study period.
Throughout the study, the Principal Investigators (PIs)
(One PI is the Director and leading physician in the study
site) will monitor the participants for adverse events.
Events determined by the PIs to be unanticipated prob-
lems involving risks to subjects or others will be re-
ported the IRB as in accordance with IRB policy.
Adverse events that are determined by the PI to not be
unanticipated problems involving risks to subjects or
others will be reported per IRB policy at the time of
continuing review. In addition, NIH will be notified of
by the PIs of all adverse events.
Research compliance and regulatory audit
The regular research compliance and regulatory audit of
this study will be conducted at GHS and performed by
Corporate Compliance. The scope of the audit will
include a review of internal controls through inquiry
and detailed sample-based testing of the following
processes: registration, visit charge, research study
charge capture and billing. The investigators’ research
records and the corresponding approved Institutional
Review Board (IRB) documents will be reviewed to
strengthen awareness of regulatory requirements and
improve the ethical conduct of research. A copy of re-
search regulatory findings will be sent to the GHS IRB.
Data management and data sharing
The Study data will be collected through RedCap (study
specific survey data) and EPIC (clinical data), which will
be maintained at GHS. Regular data review/reports will
be generated through the RedCap and EPIC to monitor
the patient enrollment, group balance, compliance, and
the time to make the reminding calls & patient incen-
tives. The study related raw data will be transferred to
Clemson University (every 6 months) for further data
merging and cleaning. The merged datasets will be
stored and maintained at Clemson University during the
study active period. A virtual machine (VM) will be
allocated for hosting the data raw and computation.
Clemson University Clemson Computing and Informa-
tion Technology (CCIT) will be responsible for the
security management of the VM. The Clemson Univer-
sity research team will be responsible for data merge
and cleaning. The cleaned dataset will be shared with
GHS team.
The Study recognizes the final National Institutes of
Health’s Statement on Sharing Research Data (NIH
Guide: February 26, 2003; Notice # NOT-OD-03032).
This Statement recognizes that the rights and privacy of
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people who participate in NIH-sponsored research must
be protected at all times including in the course of
sharing data. The Statement further recognizes that the
PIs are granted sufficient time in which to analyze and
publish their primary research initiatives. To support
NIH’s long-standing policy to share and make available
to the public the results and accomplishments of the
activities that it funds, the study team has developed the
following data sharing plan and has been approved by
NIH. Data will be shared with NIH according to NIH
existing policy. Before any data is sent to NIH, all
personal identifiers will be removed and a unique study
number will be assigned that is different from the study
ID number used by our team to add a second level of
security to protect participant confidentiality. Data sets
from different sources (i.e. laboratory, screening, ques-
tionnaire) will be created using SAS, with each partici-
pant’s data linked using the unique study ID. Each data
set will be labeled. A data dictionary of variable labels
and codes will also be provided. We propose the use of
SAS data files with accompanying data dictionaries;
however other data systems can be used to prepare these
files if preferred (such as, EXCEL, SAS or STATA). In
addition, before a public use data set is created, data
staff will review all fields to ensure that there are no
fields that might reveal the identity of a subject. For
example, providing zip code, race, and date of birth on a
subject may be used to reveal the identity of a subject if
the combination is unique.
Sample size
We calculated our sample size based on Aims 1 & 2
with the primary outcome of PTB. Based on the litera-
ture and our preliminary data, the rate of PTB was
approximately 10-16% of women in the traditional care
setting [16]. The odds ratio of comparing PTB in GPNC
to IPNC was 0.67 in the Ickovics study and 0.53 in our
own study [16, 17]. Our own work also suggests that the
risk difference of having PTB between Black women and
White women was 1.0% in the IPNC and 2.4% in the
GPNC. Taken together, it is reasonable to assume that
the relative risk of PTB in the IPNC group could range
from 10% to 16%. For aim 1, assuming the proportion of
PTB rate of 13%, our study will need N = 2,712 (1,356 in
each group) to detect the relative risk of PTB in GPBC
vs. IPNC of 0.70 with an alpha of 0.05 and a power of
90%. For aim 2, assuming the proportion of PTB rate of
0.02, our study will need N = 2,748 (1,374 in each group)
to detect reduction in risk difference of 1.4% between
Black and White women in GPNC vs. IPNC group with
an alpha of 0.05 and a power of 90%. With an estimated
15% attrition rate, we will target recruiting 3,160
(N = 1,580 in each group) women for this study.
Table 3 gives the estimated minimum number (in
each group) required to achieve an alpha of 0.05 and a
power of 80% or 90% to detect the risk ratio from 0.5 to
0.7 in Aim 1 and to detect the risk difference from 0.01 to
0.08, given the rate difference (P0) of preterm birth
between Black women and White women at the IPNC
group ranges from 2% to 3% in Aim 2, This sample size
estimates that the proposed study will have 90% power to
detect racial difference on PTB for Aim 2.
Analytic plan
Primary analyses for Aims 1, 2, and 3 will be conducted
using an intent-to-treat approach. Study participants will
be retained in their original assignment groups after the
randomization in the analysis regardless of the number
of missed visits, the use of additional services (e.g.,
progesterone), or loss to follow-up.
1. Aim 1 analysis plan: comparison of primary and
secondary outcomes for GPNC vs. IPNC. To test the
hypothesis for aim 1 that women who participated
in GPNC will have a lower rate of PTB and other
selected birth outcomes as compared to their
counterparts in IPNC, multivariate regression
models (logistic regression if the outcome is a binary
variable and linear regression if the outcome is a
continuous variable) will be employed with the
intervention assignment as the primary independent
variable. We will test the null hypothesis of
Table 3 Sample size and power calculations
Power = 80% Power = 90%
Aim 1 RR = 0.50 RR = 0.60 RR = 0.70 RR = 0.50 RR = 0.60 RR = 0.70
P0 = 0.10 435 721 1,356 582 965 1,814
P0 = 0.13 326 540 1,014 436 723 1,356
P0 = 0.16 258 427 800 345 571 1,070
Aim 2 RD = 0.01 RD = 0.014 RD = 0.018 RD = 0.01 RD = 0.014 RD = 0.018
P0 = 0.02 2,319 1,027 526 3,103 1,374 704
P0 = 0.03 3,826 1,799 995 5,121 2,048 1,332
P0: the RD of PTB in IPNC group; RR: relative risk
Abbreviation: RD = risk difference
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coefficient of main exposure variable (GPNC vs.
IPNC) equals zero. Stratified analyses will be
conducted (e.g. race/ethnicity, previous history of
PTB) to compare the primary and other outcomes
within sub-groups.
2. Aim 2 analysis plan: comparison of racial disparities
of primary and secondary outcomes for GPNC vs.
IPNC. To test the hypothesis for Aim 2 that the
Black-White differences in PTB and other selected
birth outcomes is smaller in the GPNC as compared
with that in IPNC, we will apply analyses similar to
Aim 1 but adding an interaction term of prenatal
care (GPNC vs. IPNC) with race (White vs. Black).
We will test the null hypothesis of coefficient of
interaction term equals zero. For aim 2, only women
identified themselves as either Black or White will
be included in the primary analysis. Then, we will
conduct a sensitivity analysis to see whether
including women who self-identified race as
“Hispanic ethnicity”, “Mixed race” and “Other
race” will influence the primary analysis results.
Such sensitivity analysis will be guided by the
results from the sub-groups analysis in Aim 1.
3. Aim 3 analysis plan: comparison the effects of
GPNC on maternal psychosocial (i.e. activation,
engagement, stress) and behavioral (i.e. smoking,
healthy eating, healthy practices) changes and
exploring whether improving maternal psychosocial
and health behavior outcomes will explain the
potential benefits of the GPNC on racial disparities
in birth outcomes. To address Aim 3, we will first
test whether changes in maternal health behaviors
or psychosocial factors differ by intervention and
race. To do this, a similar analytic plan as used in
Aim 1 & 2 will be applied, however, the dependent
variables will be changes of health behaviors or
psychosocial factors from baseline (~20 weeks) visit
to late pregnancy (30–36 weeks). If we observe any
significant differences in these health behaviors or
psychosocial factors by intervention or race, the
next step is to explore whether and to what
extent the differences in the intermediate health
behavior or psychosocial factors could explain the
intervention effect or racial disparities of birth
outcomes. To do so, the main multivariate
regression models will be examined with and
without adjustment for the intermediate health
behavior or psychosocial variables.
Statistical review and interim analyses
Statistical review of the study will be conducted by a
statistician periodically during the intervention phase of
the study. Interim analyses will be performed to assess
outcomes and to decide the continuation, alteration of
study design, or early termination, as appropriate. For
each of the hypothesis tests considered in this proposal,
we plan to monitor the change of the power after having
a reasonable number of patients (e.g. 50%) in each
group. In addition, some Monte Carlo simulations might
be adopted to get more accurate power estimates. If the
power reaches the desired level and is quite stable as
more patients are included gradually, we might stop
collecting new data. Such interim analyses will also be
used to monitor the patients’ safety and data quality.
Discussion
This is a protocol for a RCT evaluating whether Center-
ingPregnancy contributes to the reduction of PTB and
other poor maternal and birth outcomes, and improves
the racial disparity in PTB among medically low-risk
pregnant women. Additionally, this study will investigate
the potential mediating effects of maternal psychosocial
and health behavior factors. Findings from this project
potentially have two broad areas of action. First, findings
will build an understanding of the role of GPNC in
reducing the rate of PTB, and specifically in reducing
racial disparities in PTB. Second, establishing the super-
iority of GPNC can change the way healthcare is deliv-
ered, particularly to medically underserved populations.
Results will support public health efforts and future
research opportunities designed to improve the quality
and effectiveness of prenatal care services in promoting
positive birth outcomes and reducing racial disparities.
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